By capturing more cancer cells than blood draw screening, this device could help doctors understand a tumor’s biology and make decisions about treatment.

Researchers have shown how tumor-associated macrophages release compounds that block gemcitabine in the most common type of pancreatic cancer

A new precision medicine approach developed at the University of Michigan aims to predict cancer’s likelihood of migrating to the brain, and to aid in the search for new treatments

U-M researchers lead the field in successful protein creation, a tactic that could lead to a newer, more effective class of drugs.

The stable structure of circRNA makes it an ideal candidate for biomarkers because it can be detected in blood or urine, making it potentially useful for cancer diagnosis or prognosis.

In a new paper, researchers and ethicists urge policymakers to view immortal cells differently from other biospecimens as new rules go into effect.